Cargando…

Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis

BACKGROUND AND AIMS: Previous studies reported that serum resistin levels were remarkably changed in patients with nonalcoholic fatty liver disease (NAFLD) but the conclusions were inconsistent. The aim of this study was to investigate accurate serum resistin levels in adult patients with NAFLD. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Dongli, Chen, Jie, Liu, Shousheng, Zhang, Zengzhi, Zhao, Zhenzhen, Jin, Wenwen, Xin, Yongning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369026/
https://www.ncbi.nlm.nih.gov/pubmed/34447677
http://dx.doi.org/10.14218/JCTH.2021.00018
_version_ 1783739204334780416
author Han, Dongli
Chen, Jie
Liu, Shousheng
Zhang, Zengzhi
Zhao, Zhenzhen
Jin, Wenwen
Xin, Yongning
author_facet Han, Dongli
Chen, Jie
Liu, Shousheng
Zhang, Zengzhi
Zhao, Zhenzhen
Jin, Wenwen
Xin, Yongning
author_sort Han, Dongli
collection PubMed
description BACKGROUND AND AIMS: Previous studies reported that serum resistin levels were remarkably changed in patients with nonalcoholic fatty liver disease (NAFLD) but the conclusions were inconsistent. The aim of this study was to investigate accurate serum resistin levels in adult patients with NAFLD. METHODS: A complete literature research was conducted in the PubMed, Embase, and Cochrane Library databases, and all the available studies up to 7 May 2020 were reviewed. The pooled standardized mean difference (SMD) values were calculated to investigate the serum resistin levels in patients with NAFLD and healthy controls. RESULTS: A total of 28 studies were included to investigate the serum resistin levels in patients with NAFLD. Patients with NAFLD had higher serum resistin levels than controls (SMD=0.522, 95% confidence interval [CI]: 0.004–1.040, I(2)=95.9%). Patients with nonalcoholic steatohepatitis (NASH) had lower serum resistin levels than the healthy controls (SMD=−0.44, 95% CI: −0.83–0.55, I(2)=74.5%). In addition, no significant difference of serum resistin levels was observed between patients with NAFL and healthy controls (SMD=−0.34, 95% CI: −0.91–0.23, I(2)=79.6%) and between patients with NAFL and NASH (SMD=0.15, 95% CI: −0.06–0.36, I(2)=0.00%). Furthermore, subgroup and sensitivity analyses suggested that heterogeneity did not affect the results of meta-analysis. CONCLUSIONS: This meta-analysis investigated the serum resistin levels in adult patients with NAFLD comprehensively. Patients with NAFLD had higher serum resistin levels and patients with NASH had lower serum resistin levels than healthy controls. Serum resistin could serve as a potential biomarker to predict the development risk of NAFLD.
format Online
Article
Text
id pubmed-8369026
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher XIA & HE Publishing Inc.
record_format MEDLINE/PubMed
spelling pubmed-83690262021-08-25 Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis Han, Dongli Chen, Jie Liu, Shousheng Zhang, Zengzhi Zhao, Zhenzhen Jin, Wenwen Xin, Yongning J Clin Transl Hepatol Original Article BACKGROUND AND AIMS: Previous studies reported that serum resistin levels were remarkably changed in patients with nonalcoholic fatty liver disease (NAFLD) but the conclusions were inconsistent. The aim of this study was to investigate accurate serum resistin levels in adult patients with NAFLD. METHODS: A complete literature research was conducted in the PubMed, Embase, and Cochrane Library databases, and all the available studies up to 7 May 2020 were reviewed. The pooled standardized mean difference (SMD) values were calculated to investigate the serum resistin levels in patients with NAFLD and healthy controls. RESULTS: A total of 28 studies were included to investigate the serum resistin levels in patients with NAFLD. Patients with NAFLD had higher serum resistin levels than controls (SMD=0.522, 95% confidence interval [CI]: 0.004–1.040, I(2)=95.9%). Patients with nonalcoholic steatohepatitis (NASH) had lower serum resistin levels than the healthy controls (SMD=−0.44, 95% CI: −0.83–0.55, I(2)=74.5%). In addition, no significant difference of serum resistin levels was observed between patients with NAFL and healthy controls (SMD=−0.34, 95% CI: −0.91–0.23, I(2)=79.6%) and between patients with NAFL and NASH (SMD=0.15, 95% CI: −0.06–0.36, I(2)=0.00%). Furthermore, subgroup and sensitivity analyses suggested that heterogeneity did not affect the results of meta-analysis. CONCLUSIONS: This meta-analysis investigated the serum resistin levels in adult patients with NAFLD comprehensively. Patients with NAFLD had higher serum resistin levels and patients with NASH had lower serum resistin levels than healthy controls. Serum resistin could serve as a potential biomarker to predict the development risk of NAFLD. XIA & HE Publishing Inc. 2021-08-28 2021-05-17 /pmc/articles/PMC8369026/ /pubmed/34447677 http://dx.doi.org/10.14218/JCTH.2021.00018 Text en © 2021 Authors. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Han, Dongli
Chen, Jie
Liu, Shousheng
Zhang, Zengzhi
Zhao, Zhenzhen
Jin, Wenwen
Xin, Yongning
Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
title Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
title_full Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
title_fullStr Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
title_full_unstemmed Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
title_short Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
title_sort serum resistin levels in adult patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369026/
https://www.ncbi.nlm.nih.gov/pubmed/34447677
http://dx.doi.org/10.14218/JCTH.2021.00018
work_keys_str_mv AT handongli serumresistinlevelsinadultpatientswithnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysis
AT chenjie serumresistinlevelsinadultpatientswithnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysis
AT liushousheng serumresistinlevelsinadultpatientswithnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysis
AT zhangzengzhi serumresistinlevelsinadultpatientswithnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysis
AT zhaozhenzhen serumresistinlevelsinadultpatientswithnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysis
AT jinwenwen serumresistinlevelsinadultpatientswithnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysis
AT xinyongning serumresistinlevelsinadultpatientswithnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysis